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Background: Early endovascular recanalization of occluded vessels in acute ischemic
stroke (AIS) is a major contributor to good clinical outcome. We report the analysis of
all AIS patients throughout a 6-year experience following the deployment of a quality
initiative aiming at improving care, speed and maintaining quality for AIS treatment.
Methods: Using a prospectively collected endovascular database at a comprehensive
stroke center between 2012 and 2017, workflow/outcomes were recorded. There were
no exclusion criteria. During the first year, a quality program employing “digital-object”
technology, staff education, and workflow improvement was implemented to reduce
time-to-treatment. Using electronic recording, workflow times were collected for onset
(TO ), CT (TCT ), door (TD ), angiography-suite (TA ), groin puncture (TG ), DSA (TDSA ), and
recanalization (TR ). Recanalization time (TG -TR ) and workflow intervals were compared
at Year 1 and 6.
Results: Analysis of 382 patients (aged 71.3 ± 12.9) undergoing mechanical
thrombectomy for AIS (206 male and 176 female) was performed. Recanalization time
was significantly reduced from 82 min in 2012 to 34 min by 2017 (IQR 52–117 min and
23–49 min), a 59% reduction (P < 0.001). Further, consistent year-over-year reductions
in setup time (TA -TG ) (44% improvement) and TCT to TA times were observed. During the
same period, clinical outcome significantly improved year-over-year as measured with
the modified Rankin Scale 0–2 (33, 37, 38, 41, 53, and 58%).
Conclusions: Significant improvements were observed following the deployment of
a quality initiative enabling iterative evidence-based process improvements, thereby
sustaining significant reductions in time-to-treat and improved clinical outcomes for
AIS patients.
Keywords: endovascular, acute ischemic stroke, recanalization, mechanical thrombectomy, quality initiative,
clinical outcome

1

February 2020 | Volume 10 | Article 1251

Hassan et al.

STEPS-T Improves AIS Endovascular Outcomes

INTRODUCTION

neurointerventionalists. The following data were collected for
each patient: demographic information, clinical characteristics,
National Institutes of Health Stroke Scale (NIHSS) score at
admission and discharge, modified Rankin Scale (mRS) at 90
days, and Thrombolysis in Cerebral Infarction (TICI) scores.
All procedures were performed using biplane angiographic
systems (Innova IGS 630, GE Healthcare, Chicago, IL) equipped
with 30 cm flat panel detectors and advanced imaging capabilities
such as Cone Beam CT.

Throughout the United States there is an acute ischemic stroke
(AIS) occurring every 40 s and a stroke-related death occurring
every 4 min, thus establishing stroke as the leading contender
of morbidity and disability (1). Clinical outcomes, demonstrated
by studies, are heavily reliant on reperfusion times (2, 3). In
managing AIS cases due to large vessel occlusion, the goal
has been to achieve rapid recanalization and to reduce time
from onset to mechanical thrombectomy (MT) (4, 5). Optimal
practices to generate improvement of effective and efficient case
management remains immature and lacks a complete consensus,
despite technological advancements in managing workflow.
Studies have demonstrated that modifications and
improvements are potentially attainable at every stage of
the care workflow, where considerable emphasis has been placed
to reduce transport times (4, 6–16). The quality of care in AIS
has been shown to be influenced by operational modifications
such as the implementation of evidence-based stroke protocols,
improved staff education and training, and prioritization of
hospital resources (17, 18). The accumulation of these findings
is in agreement with the necessity to improve efficiencies at
individual stages of the care workflow, which is achievable
through a methodologically incorporated alteration of the whole
care pathway.
The main goal of this study is to determine the 6-year
impact of STEPS-T (Stroke Triage Education and Procedure
Standardization and Technology) on improving the time to treat,
and thus determine whether clinical outcomes, measured using
modified Rankin Scale (mRS), will show improvement in the
study period, with a real world AIS population.

Steps-T
The STEPS-T program is an integrated approach designed to
reduce door-to-recanalization time. The program fundamentally
revolves around three interlaced principles affecting the speed
and quality of care: (1) procedure workflow, (2) technologies, and
(3) education. Additionally, each workflow step is recorded, using
“digital objects,” or macro-enabled systems, which allow staff in
the care pathway to remain connected, as stated by the American
Heart Association Data Summit on the importance of integrating
digital objects in modern stroke care (19, 20). Prior evidence
indicates the importance of these three interrelated domains (15,
16, 18). These “digital objects,” custom built for our program by
General electric (GE), were chosen to create time-stamps and to
subsequently measure time metrics in the procedural workflow.
The “digital objects” were captured manually by staff and housed
in the Electronic Medical Records (EMR). By allocating workflow
in the biplane angiography suite into steps, treatment time was
reduced, and actions and actors of the intervention, i.e., nurses,
technologists, and physicians, were able to operate in a timely and
standardized fashion (Figure 1).
There were three stages involved in implementing STEPST at the comprehensive stroke center. Daily integrated and
tailored formal training sessions were performed for the initial
30 days which included shadowing to customize imaging
system settings and device training in order to improve their
use. Thereafter advanced training was conducted monthly for
6 months to improve on weaknesses throughout the stroke
treatment time periods and to optimize the work flow. Processes
were later modified and amended, per clinical necessity, by
the neurointerventionalist, nursing staff, technology provider
and administration. Existing staff members were required to
participate in the training, and to provide peer-to-peer training
for ∼3–6 months for all new staff who would shadow on-call
procedures. Also, as new technology emerged staff was educated
on its implementation as soon as possible.
Staff was briefed about the metrics monthly at Neuroscience
Departmental meetings which were overseen by the two
operating neurointerventionalists. Fine tuning and areas of
improvement were discussed and identified through reports
generated over time. Continuous modifications were made after
identifying areas of potential improvement in treatment time
and other areas, including changes in inclusion criteria after the
DAWN study was initiated (21).

METHODS
Patient Data Collection and Imaging
Procedures
A prospectively maintained endovascular registry of patients
treated with MT for AIS from 2012 to 2017 was obtained
after institutional review board approval at Valley Baptist
Medical Center Harlingen, a comprehensive, high-volume, stroke
treatment center in the United States. The population included
patients who presented with intracranial large-vessel occlusion
(LVO) or distal occlusion, posterior circulation occlusions, or
carotid occlusions and were eligible for MT after undergoing a
standard computed tomography (CT) protocol [Alberta Stroke
Program Early CT Score (ASPECTS) ≥6], confirmation of LVO,
posterior circulation, or carotid occlusions on CT angiography,
and absence of intracranial hemorrhage (ICH). Patients received
intravenous (IV) tissue plasminogen activator (t-PA) after CT
scan, when indicated (36% of the AIS patient population was
administered an intravenous thrombolytic agent). All patients
were imaged with CT and computed tomography angiography
(CTA). All stroke thrombectomy patients were included, except
nine cases (2%) had to be excluded during the data analysis due
to missing data.
All procedures were performed by two Accreditation Council
for Graduate Medical Education (ACGME) fellowship-trained
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Workflow Data
The use of digital objects (macros), appointed to each individual
step in the care pathway, allowed for collection of the workflow
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FIGURE 1 | Workflow in the biplane suite illustrating the parallel nature of tasks by the different actors in the room. The “interventional time” starts when the patient
arrives in the biplane suite. Tech, technician.

(10.9%) presented with posterior circulation occlusions, and 96
patients (25.5%) presented with carotid occlusions necessitating
angioplasty and or stenting in addition to MT (Table 1). The
technique used in 95% of our cases involves deploying a
stentriever, “kissing” the clot with a distal aspiration catheter,
turning on suction, followed by pulling both the stentriever and
distal aspiration catheter back together.
Consistent year-over-year reductions in setup time (TA -TG )
(23–13 min) were observed, representing a 44% improvement,
accompanied by a reduction in TCT -TA times (Figure 2).
The median total intervention time (TA -TR ) and door to
recanalization time (TD -TR ), were also significantly reduced
from 116 min in 2012 to 51 min in 2017 and 207 min in 2012
to 144 min in 2017, respectively. Furthermore, intervention time
remained constant throughout year 2014–year 2017 with a
median of 51.5 ± 0.5 min, while door to recanalization time
(TD -TR ) experienced a constant decline throughout the 6-year
period, with a slight increase in 2016 from 126 to 144 min in
2017. Approximately 75% (Ratio of the linear regressions: y =
−15.166x + 217.01, R² = 0.8528/y = −8.8571x + 77, R² =
0.6948) of the total intra-hospital time reduction is attributed to
the intra-biplane time (Figure 2).
Moreover, throughout the 6-year study period, median
procedure time (TG–TR) for all AIS patients undergoing MT
was significantly reduced from 82 min in 2012 to 34 min by 2017
(IQR 52–117 min and 23–49 min, respectively), representing a
53% reduction (P < 0.001) (Figure 2).
Since this study includes all AIS patients, recanalization
time by procedure type (i.e., LVO MT, Posterior circulation,
angioplasty + MT) was explored. The results displayed an overall
reduction in both recanalization time for LVO and posterior
circulation occlusion procedures from 2013 to 2017 (Figure 2).

data in a step-by-step manner. Using the Mac-Lab Hemodynamic
Recording System (GE Healthcare, Chicago, IL) in the biplane
suite, the times for each interventional/procedural step were
recorded as digital objects. This permitted utilization of the
customized step-by-step macro components for collection
of time stamps, device(s) information, and medication
administration(s). The overall times for each component in
the care pathway were recorded and collected which include:
patient onset time (TO ), computed tomography time (TCT),
arrival time at the center (door time, TD ), arrival time at the
angiography suite (TA ), time of groin puncture (TG ), acquisition
of first digital subtraction angiography (DSA) (TDSA ), and time
of recanalization (TR ).

Statistical Analysis
Descriptive summaries were designated for each of the workflow
intervals, including setup time (TA -TG ), catheterization time (TG
until completion of TDSA and TM ), and clot retrieval time (TM TR ). The primary measures of total intervention (from TA to TR )
and recanalization time (from TG to TR ) were analyzed using a
Wilcoxon rank-sum test. Workflow times and admission NIHSS
scores were compared year to year from 2012 through the 6year period using Kruskal-Wallis test. Results were classified as
significant when p < 0.05.

RESULTS
We analyzed a total of 377 patients (mean age: 71.3 ± 12.9
years; 46% female), representing clinical characteristics common
in an AIS population, who underwent MT. Of the 377 patients
presenting with AIS throughout the 6-years, 240 patients
(63.6%) presented with LVOs (anterior circulation), 41 patients
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years. Analyzing the last 3-years together, 90-day mRS of 0–2
was equal to ∼50% (Figure 3). In addition to the patients with
an mRS of 0–2 at 90 days, patients with an mRS 3–6 were also
analyzed throughout years 2012–2017, giving a more holistic
representation of the AIS population (see Graph 1).
There was no significant difference in recanalization rates
(TICI 2b-3) throughout the 6-years, but an increase can be
appreciated between 2012 and 2013 (73–92%, NS) (Figure 3). In
the same 6-year period, the median admission NIHSS remained
stable (18, 18, 16, 16, 16, 18) along the successive years for all AIS
patients (Table 1).

TABLE 1 | Population characteristics.
Data

Value
377

N
Age in years, mean (std)

71.3 (12.9)

Ethnicity N (%)
Hispanic

270 (71%)

White

104 (27%)

Asian

2 (1%)

African American
Weight in kg, mean (std)

1 (1%)
81.5 (20.4)

Sex N (%)
Female

173 (46%)

Male

203 (54%)

DISCUSSION

Comorbidities
Smoker

38 (10%)

Diabetes

176 (47%)

Hypertension

345 (92%)

Atrial fibrillation

119 (32%)

Coronary artery disease

117 (31%)

Congestive heart failure

40 (11%)

Our analysis of AIS patients during the 6-year period included
patients that presented with anterior LVOs, posterior LVOs,
and tandem lesions (requiring initial angioplasty followed by
MT). There were no exclusions, thus depicting a tangible
representation of the “real world” AIS population. The
accumulative analysis of these patients, generated the following
summarized results: a decrease in setup (TA -TG ), median total
intervention (TA -TR ), and door to recanalization time (TD TR ) of 44, 56, and 30.4% respectively through 2012–2017,
a total median procedure time (TG -TR ) reduction of 53%,
sub-classified by procedure type [LVO (TG -TR ) reduced by
27.3%, posterior circulation occlusion (TG -TR ) decreased by
31.8%, while angioplasty and MT (TG -TR ) were increased by
13.34%], mRS improvement from 33% in 2012 to 58% in 2017,
recanalization rates (TICI 2b-3) showed an overall increase from
73% in 2012 to 90% in 2017, and no significant difference
in demographics and admission NIHSS scores throughout
the 6-years.
Every 30-min delay in angiographic reperfusion reduced
the relative likelihood of a good clinical outcome (mRS 0–2
at 90 days) by 15% (22). Prior studies have investigated the
predictors of good clinical outcome after endovascular treatment
for AIS and the need to reduce time-to-treatment. The need for
implementation of workflow techniques to reduce procedural
times are highlighted in a study by Settecase et al. (23), where
the integration of a stroke cart (containing all procedural
MT equipment), parallel staff workflows, and use of conscious
sedation reduced in-room time to groin puncture (−21.3 min, p
< 0.0001), in-room to on-clot time (−24.1 min, p = 0.001), and
in-room to reperfusion time (−29.5 min, p = 0.01) for 47 patients
(19 pre- and 28 post-implementation) with LVO who underwent
MT (23). In our analysis, we included additional procedural
types (posterior circulation occlusions and tandem lesions) and
reached a similar consensus with a reduction in setup (TA -TG )
and procedure (TG -TR ) time (−10 and −48 min, respectively)
throughout the 6-years.
In an additional study, reductions were centralized
around door to groin-puncture time (DGPT) for 16 LVO
patients (throughout 6 months) who underwent MT after
implementation of time reduction techniques. The conclusion
was that “An iterative quality improvement process can
significantly improve DGPT” (24). Thus, reductions at different

Procedure by type:
Large vessel occlusion MT

240

Posterior circulation

41

Angioplasty (+MT)

96

Site of occlusion:
Carotid terminus

111

MCA

207

ACA

17

BA/PCA

42

Admission NIHSS, median (IQR)
2012

18 (13.5–23)

2013

18 (11–22)

2014

16 (11.5–21.5)

2015

16 (10–21)

2016

16 (10–21)

2017

18 (11.5–23)

NIHSS, National Institute of Health Stroke Scale; MT, mechanical thrombectomy. MCA,
Middle Cerebral Artery; ACA, Anterior Cerebral Artery; BA, Basilar Artery; PCA, Posterior
Cerebral Artery.

Through 2013–2017, LVO MT patients remained somewhat
constant with a median recanalization time of 16:41 ± 0.48 min,
except between 2016 and 2017 where a significant reduction
in recanalization time of 16.5–12 min can be appreciated (a
reduction of 27.3%). Procedural recanalization time for posterior
circulation occlusions display an overall reduction from 22 to
15 min (31.8% reduction) from 2013 to 2017. Recanalization
times for patients requiring angioplasty (carotid occlusions) and
MT exhibited an overall increase of 1.9 min (13.34%), with
oscillations, from 2013 to 2017 (Figure 2).
During the same 6-year study period, clinical outcome also
significantly improved year-over-year as measured with the
modified Rankin Scale (mRS) 0–2 at 90 days, evolving from 33%
during 2012, to 37, 38, 41, 53, and 58% during the following
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FIGURE 2 | (A) Intraprocedural time: median setup time and puncture to recanalization time (p-values of individual years 2012–2017; 0.08, <0.001, 0.26, 0.35, 0.71);
(B) periprocedural time: median interventional time and door to recanalization time 2012–2017 (Ratio of the linear regressions: y = −15.166x + 217.01, R² =
0.8528/y = −8.8571x + 77, R² = 0.6948); (C) intraprocedural time: median interventional time; (D) periprocedural time: recanalization time by type of procedure
(LVO, large vessel occlusion; MT, mechanical thrombectomy).

FIGURE 3 | (A) modified Rankin Scale (mRS) ≤2 at 90 days 2012–2017; (B) thrombolysis in cerebral infarction (TICI) post-mechanical thrombectomy 2012–2017.
The size of the bubble is proportionate to the sample size per year.

the role an integrated program (STEPS-T), implemented
to reduce time-to-treatment, plays in the AIS picture.
Time-to-treatment is an important metric to assess quality
improvements to workflow and has proven to directly affect
stroke outcomes (12).
This study demonstrated that total intervention and
recanalization times in all stroke patients was reduced over
the 6-year period by implementation of the STEPS-T program
and through the experience of the operators and staff. Total

stages of the care pathway are possible, and are in concurrence
with generating a more favorable outcome. Also, the HERMES
analysis (Highly Effective Reperfusion Evaluated in Multiple
Endovascular Stroke Trials) reported a linear reduction in
chances of good outcome with increasing time between onset
and MT (17).
Overall, total intervention, recanalization, and setup time
were reduced in this 6-year period. This study highlights the
importance of time-to-treatment by endovascular therapy and

Frontiers in Neurology | www.frontiersin.org
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GRAPH 1 | Bar graph of modified Rankin Scale (mRS 0–6) at 90 days post-mechanical thrombectomy.

intervention time was reduced by 56%, recanalization time by
30.4%, and setup time by 44%. mRS, as an outcome, was also
improved from 33 to 58%. Moreover, STEPS-T sustainably
reduced times along every stage of the care pathway.
Even though much attention has been placed on reducing
patient transfer time to shorten the overall care pathway,
manipulation of treatment duration, not at the expense of quality
care, has also been demonstrated. A harmonized and consistent
approach has been reported, by McTaggart et al., to reduce
time from groin puncture to recanalization (4). The McTaggart
et al. study was conducted over a 1-year observational period
of a smaller cohort (N = 22, mean 37 min, CI: 32.1–42.5),
excluding posterior circulation and tandem lesion cases, and
clinical outcomes were not reported at 90 days.
Limitations to this study included the retrospective nature of
data collection and analysis that prevented randomization of the
approach. Also, detailed analysis was not performed to assess
the evolution from the time of onset to treatment over the 6year period. Due to the DAWN trial (clinicaltrials.gov number,
NCT02142283) criteria there was inclusion of wake-up strokes
exceeding the 6-h window, which slightly affected the 2016–
2017 data, however patients who underwent MT throughout
2012–2016 were free from any inclusion or exclusion criteria.
The 2016 data witnessed increased AIS patient recruitment,
following publications of studies that proved superiority of MT to
previously established standard of care (5, 7, 25–27). Ultimately
leading to an abnormally increased staff turnover in 2016,
affecting our demanding training approach. Despite the lack of
development to our practice, we appreciated a reduction in time
and an improvement in operator skills performing MT, which is
likely due to the increase in AIS patients throughout the study
independent of the STEPS-T application. Also, it is worth noting
is that 95% of our cases were performed using stent-retriever
with aspiration. STEPS-T implemented in a lower-volume center
may prove more challenging and time consuming, necessitating

Frontiers in Neurology | www.frontiersin.org

multi-center sharing and standardization (28). Some barriers
to the implementation to STEPS-T included initial staff biases,
anxiety, and the concern over increased workload. Continuous
staff training, shadowing, and education helped to improve these
issues over the course of the first couple of months. Increased
MT volume facilitated implementation of the program. Support
from hospital education and industry further refined their skills.
For new hires a minimum of 3 months shadowing on call helped
transition them to reach the program’s goals. The future of stroke
treatment will require new education initiatives to improve the
onset to door and door to catheterization lab times to continue
improvements in stroke outcomes.

CONCLUSION
STEPS-T continues to prove beneficial in reducing total
intervention and recanalization time, consequently generating
an improvement in mRS, even when including “real world”
patients presenting with posterior circulation and tandem lesions
(angioplasty followed by MT). Further standardization of digital
objects and staff training will be required to continually sustain
the evidence-based improvements at all steps of the acute stroke
care pathway.
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